Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000229797

Medchemexpress LLC Thalidomide-O-amido- 50mg | 2022182-58-5 | 502.4 g/mol | C20H21F3N4O8 | 50 MG
SDP

Catalog No. 5000229797
Encompass_Preferred

Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that combines a thalidomide-based cereblon ligand with a short C3 linker. Supplied as the trifluoroacetate (TFA) salt, it is intended for use in PROTAC design and E3 ligase ligand-linker chemistry research.

  • Synthesized cereblon ligand-linker conjugate for PROTAC research.
  • Trifluoroacetate (TFA) salt form.
  • Molecular formula C20H21F3N4O8, molecular weight 502.4 g/mol.
  • Useful as a building block for E3 ligase recruitment in degrader design.
  • Available in 50 MG packaging.

Catalog No. 50-002-29797 Supplier Medchemexpress LLC Supplier No. HY115560A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that combines a thalidomide-based cereblon ligand with a short C3 linker. Supplied as the trifluoroacetate (TFA) salt, it is intended for use in PROTAC design and E3 ligase ligand-linker chemistry research.

  • Synthesized cereblon ligand-linker conjugate for PROTAC research.
  • Trifluoroacetate (TFA) salt form.
  • Molecular formula C20H21F3N4O8, molecular weight 502.4 g/mol.
  • Useful as a building block for E3 ligase recruitment in degrader design.
  • Available in 50 MG packaging.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.